Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Cell of origin role in cancer stem cell and GBM phenotype

Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA
Cell of origin role in cancer stem cell and GBM phenotype ( Dr Luis Parada - Memorial Sloan Kettering Cancer Centre, New York, USA )
27 Apr 2016

New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations

Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia
New RAF-targeted therapeutic shows early promise against tumours with BRAF and RAS mutations ( Dr Jayesh Desai - Royal Melbourne Hospital, Melbourne, Australia )
27 Apr 2016

MINDACT breast cancer clinical trial: First results and impact on future trial design

Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium
MINDACT breast cancer clinical trial: First results and impact on future trial design ( Dr Martine Piccart - Jules Bordet Institute, Brussels, Belgium )
27 Apr 2016

Breast cancer research news from AACR President Nancy Davidson

Dr Nancy Davidson - AACR President, Philadelphia, USA
Breast cancer research news from AACR President Nancy Davidson ( Dr Nancy Davidson - AACR President, Philadelphia, USA )
27 Apr 2016

BSH 2016: Expert discussion on front line care in CLL

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on front line care in CLL ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

BSH 2016: Expert discussion on idelalisib

Dr George Follows and Dr Andrew Zelenetz
BSH 2016: Expert discussion on idelalisib ( Dr George Follows and Dr Andrew Zelenetz )
27 Apr 2016

Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance

Dr Marianne Ratcliffe - AstraZeneca, UK
Comparison of three different PD-L1 diagnostic tests shows a high degree of concordance ( Dr Marianne Ratcliffe - AstraZeneca, UK )
26 Apr 2016

Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy

Dr Nicholas McGranahan - Crick Institute, London, UK
Mutational clonality and intratumour heterogeneity as biomarkers for cancer immunotherapy ( Dr Nicholas McGranahan - Crick Institute, London, UK )
26 Apr 2016

Risk of breast cancer after chest radiotherapy may be affected by genetics

Dr Lindsay Morton - National Cancer Institute, Bethesda, USA
Risk of breast cancer after chest radiotherapy may be affected by genetics ( Dr Lindsay Morton - National Cancer Institute, Bethesda, USA )
26 Apr 2016

Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy

Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA
Retroviral replicating vectors for cancer-targeted gene therapy and immunotherapy ( Dr Noriyuki Kasahara - Miami University School of Medicine, Miami, USA )
26 Apr 2016

NY-ESO-1 immunotherapy for ovarian cancer

Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA
NY-ESO-1 immunotherapy for ovarian cancer ( Dr Kunle Odunsi - Roswell Park Cancer Institute, Buffalo, USA )
26 Apr 2016

Imaging tumour habitats - life at the edge

Robert Gillies - Moffitt Cancer Center, Tampa, USA
Imaging tumour habitats - life at the edge ( Robert Gillies - Moffitt Cancer Center, Tampa, USA )
26 Apr 2016